363 related articles for article (PubMed ID: 19144690)
1. The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity.
Pabla N; Murphy RF; Liu K; Dong Z
Am J Physiol Renal Physiol; 2009 Mar; 296(3):F505-11. PubMed ID: 19144690
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin nephrotoxicity: a review of the literature.
Manohar S; Leung N
J Nephrol; 2018 Feb; 31(1):15-25. PubMed ID: 28382507
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin.
Chang C; Hu Y; Hogan SL; Mercke N; Gomez M; O'Bryant C; Bowles DW; George B; Wen X; Aleksunes LM; Joy MS
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640195
[TBL] [Abstract][Full Text] [Related]
4. L-tetrahydropalmatine attenuates cisplatin-induced nephrotoxicity via selective inhibition of organic cation transporter 2 without impairing its antitumor efficacy.
Li C; Li L; Yi Y; Wang W; Yuan J; Tan F; Fang D; Zeng S; Zhou H; Jiang H
Biochem Pharmacol; 2020 Jul; 177():114021. PubMed ID: 32389634
[TBL] [Abstract][Full Text] [Related]
5. Saving ears and kidneys from cisplatin.
Wensing KU; Ciarimboli G
Anticancer Res; 2013 Oct; 33(10):4183-8. PubMed ID: 24122981
[TBL] [Abstract][Full Text] [Related]
6. Klotho has dual protective effects on cisplatin-induced acute kidney injury.
Panesso MC; Shi M; Cho HJ; Paek J; Ye J; Moe OW; Hu MC
Kidney Int; 2014 Apr; 85(4):855-70. PubMed ID: 24304882
[TBL] [Abstract][Full Text] [Related]
7. Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions.
Ciarimboli G; Deuster D; Knief A; Sperling M; Holtkamp M; Edemir B; Pavenstädt H; Lanvers-Kaminsky C; am Zehnhoff-Dinnesen A; Schinkel AH; Koepsell H; Jürgens H; Schlatter E
Am J Pathol; 2010 Mar; 176(3):1169-80. PubMed ID: 20110413
[TBL] [Abstract][Full Text] [Related]
8. Membrane transporters as mediators of cisplatin side-effects.
Ciarimboli G
Anticancer Res; 2014 Jan; 34(1):547-50. PubMed ID: 24403515
[TBL] [Abstract][Full Text] [Related]
9. Relevance of copper transporter 1 and organic cation transporters 1-3 for oxaliplatin uptake and drug resistance in colorectal cancer cells.
Buß I; Hamacher A; Sarin N; Kassack MU; Kalayda GV
Metallomics; 2018 Mar; 10(3):414-425. PubMed ID: 29417972
[TBL] [Abstract][Full Text] [Related]
10. PPAR-α Deletion Attenuates Cisplatin Nephrotoxicity by Modulating Renal Organic Transporters MATE-1 and OCT-2.
Freitas-Lima LC; Budu A; Arruda AC; Perilhão MS; Barrera-Chimal J; Araujo RC; Estrela GR
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049997
[TBL] [Abstract][Full Text] [Related]
11. Influence of Oct1/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-beta-D-glucosaminidase.
Franke RM; Kosloske AM; Lancaster CS; Filipski KK; Hu C; Zolk O; Mathijssen RH; Sparreboom A
Clin Cancer Res; 2010 Aug; 16(16):4198-206. PubMed ID: 20601443
[TBL] [Abstract][Full Text] [Related]
12. Glutamine protects against cisplatin-induced nephrotoxicity by decreasing cisplatin accumulation.
Kim HJ; Park DJ; Kim JH; Jeong EY; Jung MH; Kim TH; Yang JI; Lee GW; Chung HJ; Chang SH
J Pharmacol Sci; 2015 Jan; 127(1):117-26. PubMed ID: 25704027
[TBL] [Abstract][Full Text] [Related]
13. Role of the copper transporter, CTR1, in platinum-induced ototoxicity.
More SS; Akil O; Ianculescu AG; Geier EG; Lustig LR; Giacomini KM
J Neurosci; 2010 Jul; 30(28):9500-9. PubMed ID: 20631178
[TBL] [Abstract][Full Text] [Related]
14. Uptake of compounds that selectively kill multidrug-resistant cells: the copper transporter SLC31A1 (CTR1) increases cellular accumulation of the thiosemicarbazone NSC73306.
Fung KL; Tepede AK; Pluchino KM; Pouliot LM; Pixley JN; Hall MD; Gottesman MM
Mol Pharm; 2014 Aug; 11(8):2692-702. PubMed ID: 24800945
[TBL] [Abstract][Full Text] [Related]
15. A Multicompartment Human Kidney Proximal Tubule-on-a-Chip Replicates Cell Polarization-Dependent Cisplatin Toxicity.
Nieskens TTG; Persson M; Kelly EJ; Sjögren AK
Drug Metab Dispos; 2020 Dec; 48(12):1303-1311. PubMed ID: 33020068
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin ototoxicity in rat cochlear organotypic cultures.
Ding D; He J; Allman BL; Yu D; Jiang H; Seigel GM; Salvi RJ
Hear Res; 2011 Dec; 282(1-2):196-203. PubMed ID: 21854840
[TBL] [Abstract][Full Text] [Related]
17. Selective Inhibition on Organic Cation Transporters by Carvedilol Protects Mice from Cisplatin-Induced Nephrotoxicity.
Guo D; Yang H; Li Q; Bae HJ; Obianom O; Zeng S; Su T; Polli JE; Shu Y
Pharm Res; 2018 Sep; 35(11):204. PubMed ID: 30191328
[TBL] [Abstract][Full Text] [Related]
18. Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals.
Ishida S; Lee J; Thiele DJ; Herskowitz I
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14298-302. PubMed ID: 12370430
[TBL] [Abstract][Full Text] [Related]
19. Germacrone Reduces Cisplatin-Induced Toxicity of Renal Proximal Tubular Cells via Inhibition of Organic Cation Transporter.
Soodvilai S; Meetam P; Siangjong L; Chokchaisiri R; Suksamrarn A; Soodvilai S
Biol Pharm Bull; 2020; 43(11):1693-1698. PubMed ID: 33132314
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin Protease Controls Copper and Cisplatin Accumulation via Cleavage of the Ctr1 Metal-binding Ectodomain.
Öhrvik H; Logeman B; Turk B; Reinheckel T; Thiele DJ
J Biol Chem; 2016 Jul; 291(27):13905-13916. PubMed ID: 27143361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
